Tagrisso (Osimertinib) 80mg x 10 Tablets (Osimertinib)

Tagrisso (Osimertinib) is a targeted therapy used for the treatment of non-small cell lung cancer (NSCLC) that is characterized by specific mutations in the epidermal growth factor receptor (EGFR). This medication is particularly effective for patients whose cancer has progressed after prior EGFR-targeted therapy.

Each package contains 10 tablets of Osimertinib, with a dosage strength of 80 mg per tablet. This convenient formulation allows for easy adherence to the prescribed treatment regimen. The primary action of Tagrisso is to inhibit the growth of cancer cells by blocking the activity of mutated EGFR, which is crucial for tumor growth and survival.

Some notable benefits of Tagrisso include:

• Proven efficacy in reducing tumor size and delaying disease progression in patients with EGFR T790M mutation.


• Oral administration, providing a non-invasive option for cancer treatment.


• Targeted action that minimizes damage to healthy cells, potentially leading to fewer side effects compared to traditional chemotherapy.


• Ability to cross the blood-brain barrier, which is particularly beneficial for patients with brain metastases.

Common side effects may include diarrhea, rash, and fatigue; however, many patients tolerate Tagrisso well. Regular monitoring and consultation with healthcare professionals are essential to manage any side effects and to assess treatment effectiveness.

Tagrisso represents a significant advancement in the management of advanced NSCLC, offering hope and improved outcomes for patients facing this challenging diagnosis.

• Osimertinib


• Excipients (may include):


• Microcrystalline cellulose


• Hydroxypropyl cellulose


• Magnesium stearate


• Opadry complete film coating system

Tagrisso (Osimertinib) is a medication used primarily for the treatment of certain types of non-small cell lung cancer (NSCLC). To ensure the best results and safety while using this medication, please follow these detailed instructions:

1. Consult Your Doctor: Before starting Tagrisso, consult your healthcare provider to confirm that this medication is appropriate for your condition. Discuss any allergies, existing health issues, and other medications you are currently taking.


2. Dosage: The typical dosage for Tagrisso is one tablet of 80 mg taken once daily. It is essential to take the medication at the same time each day to maintain consistent levels in your bloodstream.


3. Administration: Swallow the tablet whole with a glass of water. Do not crush or chew the tablet, as this can affect how the medication is absorbed in your body.


4. With or Without Food: Tagrisso can be taken with or without food. However, it is advisable to choose a consistent approach—either always take it with food or always take it on an empty stomach.


5. Missed Dose: If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for a missed dose.


6. Adverse Effects: Be aware of potential side effects, which may include diarrhea, skin rashes, fatigue, or decreased appetite. Report any severe or persistent side effects to your healthcare provider immediately.


7. Regular Monitoring: Regular follow-up appointments with your healthcare provider are necessary to monitor your response to the treatment and adjust the dosage if needed. Blood tests may be performed to check your liver function and overall health.


8. Store Properly: Keep Tagrisso at room temperature, away from moisture and heat. Ensure it is stored out of reach of children and pets.


9. Discontinuation: Do not stop taking Tagrisso without consulting your healthcare provider, as sudden discontinuation may affect your treatment outcomes.

Always follow your healthcare provider's instructions and the information provided with your medication. If you have any questions or concerns about using Tagrisso, do not hesitate to reach out to your healthcare professional for guidance.